XBB.1.5 vaccine booster shows promise against new Omicron variants in latest study
In a recent study posted to bioRxiv preprint* server, researchers observed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB.1.5 monovalent vaccine booster induces robust neutralizing antibodies (nAbs) against emergent variants. SARS-CoV-2 Omicron XBB sub-variants have reduced the effectiveness of current vaccines, leading to the authorization of monovalent XBB.1.5 vaccines. While preliminary evidence suggests that … Read more
